-
Je něco špatně v tomto záznamu ?
Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers
L. Hosak, M. Preiss, J. Bazant, A. Tibenska, R. Cermakova, E. Cermakova
Jazyk angličtina Země Chorvatsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
22706418
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- kognitivní poruchy chemicky indukované komplikace MeSH
- lidé středního věku MeSH
- lidé MeSH
- methamfetamin škodlivé účinky MeSH
- mladiství MeSH
- neuropsychologické testy MeSH
- poruchy spojené s užíváním amfetaminu komplikace psychologie MeSH
- stimulanty centrálního nervového systému škodlivé účinky MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Methamphetamine is a neurotoxic agent. Its chronic abuse may result in cognitive impairment with negative consequences for patients' treatment and rehabilitation. The aim of the study was to compare Wisconsin Card Sorting Test profiles of Czech subjects dependent on methamphetamine with healthy individuals. SUBJECTS AND METHODS: Forty-three hospitalized Czech Caucasian patients including twenty-seven men at the average age of 25.3±5.2 years dependent on methamphetamine for 6.2±3.3 years were assessed by the Wisconsin Card Sorting Test. We used the same neurocognitive test for the comparison group of healthy controls with the same ethnicity (N=52, men N=28, average age of 38.7±12.1 years). We applied the Chi-Square Test, Two-Sample T Test, Mann-Whitney U Test and Kolmogorov-Smirnov Test to compare methamphetamine dependent patients with healthy volunteers. RESULTS: All recorded Wisconsin Card Sorting Test parameters were significantly different in the group of methamphetamine dependent patients versus healthy volunteers (P=0.04-0.006; Mann-Whitney U Test, Two-Sample T Test). The results showed a higher error rate and a smaller achievement quality in the patients as against healthy subjects. We ascertained a significant cognitive deterioration in the patients as compared to healthy volunteers even if the average patients' achievements were in the normal range according to the test norms. CONCLUSIONS: A cognitive impairment was present in the group of patients as compared to healthy controls. Better understanding of neurocognitive symptoms in methamphetamine dependent subjects should help to generate modern therapeutic approaches, both pharmacological and psychosocial, to prevent or attenuate the long-term negative consequences of methamphetamine use disorders.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034449
- 003
- CZ-PrNML
- 005
- 20160610080601.0
- 007
- ta
- 008
- 121023s2012 ci f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)22706418
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ci
- 100 1_
- $a Hosák, Ladislav, $d 1962- $7 jn20010309154 $u Department of Psychiatry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. hosak@lfhk.cuni.cz
- 245 10
- $a Comparison of Wisconsin Card Sorting Test results between Czech subjects dependent on methamphetamine versus healthy volunteers / $c L. Hosak, M. Preiss, J. Bazant, A. Tibenska, R. Cermakova, E. Cermakova
- 520 9_
- $a BACKGROUND: Methamphetamine is a neurotoxic agent. Its chronic abuse may result in cognitive impairment with negative consequences for patients' treatment and rehabilitation. The aim of the study was to compare Wisconsin Card Sorting Test profiles of Czech subjects dependent on methamphetamine with healthy individuals. SUBJECTS AND METHODS: Forty-three hospitalized Czech Caucasian patients including twenty-seven men at the average age of 25.3±5.2 years dependent on methamphetamine for 6.2±3.3 years were assessed by the Wisconsin Card Sorting Test. We used the same neurocognitive test for the comparison group of healthy controls with the same ethnicity (N=52, men N=28, average age of 38.7±12.1 years). We applied the Chi-Square Test, Two-Sample T Test, Mann-Whitney U Test and Kolmogorov-Smirnov Test to compare methamphetamine dependent patients with healthy volunteers. RESULTS: All recorded Wisconsin Card Sorting Test parameters were significantly different in the group of methamphetamine dependent patients versus healthy volunteers (P=0.04-0.006; Mann-Whitney U Test, Two-Sample T Test). The results showed a higher error rate and a smaller achievement quality in the patients as against healthy subjects. We ascertained a significant cognitive deterioration in the patients as compared to healthy volunteers even if the average patients' achievements were in the normal range according to the test norms. CONCLUSIONS: A cognitive impairment was present in the group of patients as compared to healthy controls. Better understanding of neurocognitive symptoms in methamphetamine dependent subjects should help to generate modern therapeutic approaches, both pharmacological and psychosocial, to prevent or attenuate the long-term negative consequences of methamphetamine use disorders.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a poruchy spojené s užíváním amfetaminu $x komplikace $x psychologie $7 D019969
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a stimulanty centrálního nervového systému $x škodlivé účinky $7 D000697
- 650 _2
- $a kognitivní poruchy $x chemicky indukované $x komplikace $7 D003072
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a methamfetamin $x škodlivé účinky $7 D008694
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neuropsychologické testy $7 D009483
- 651 _2
- $a Česká republika $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Preiss, Marek, $d 1967- $7 mzk2002142240 $u Prague Psychiatric Center, and University of New York in Prague, Czech Republic
- 700 1_
- $a Bažant, Jan $7 js20081127005 $u Department of Psychiatry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. hosak@lfhk.cuni.cz
- 700 1_
- $a Tibenská, Andrea, $d 1981- $7 xx0099533 $u Department of Psychiatry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. hosak@lfhk.cuni.cz
- 700 1_
- $a Čermáková, Radka $7 xx0070775 $u Department of Psychiatry, Charles University in Prague, Faculty of Medicine in Hradec Kralove, and University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic. hosak@lfhk.cuni.cz
- 700 1_
- $a Čermáková, Eva, $d 1952- $7 mzk2007401286 $u Computer Technology Center, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic
- 773 0_
- $w MED00006897 $t Psychiatria Danubina $x 0353-5053 $g Roč. 24, č. 2 (2012), s. 188-193
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22706418 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20160610080737 $b ABA008
- 999 __
- $a ok $b bmc $g 956459 $s 791946
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 24 $c 2 $d 188-193 $i 0353-5053 $m Psychiatria Danubina $n Psychiatr Danub $x MED00006897
- LZP __
- $b NLK122 $a Pubmed-20121023